Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

According to a new study women of reproductive age who are using the modern oral contraceptive pills or patches and rings that contain a combination of estrogen and progesterone are at a reduced risk for ovarian cancer. The study was published in the recent issue of the British Medical Journal (BMJ).

27 Sep 2018

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.

19 Sep 2018

Researchers reveal how rapidly spreading ovarian cancer cells take the next steps

In nearly 80 percent of women with ovarian cancer, the disease has already spread to the omentum before it was diagnosed. Within the omentum -; a large, energy-dense fat pad that covers the intestines -; the cancer grows even faster.

7 Sep 2018

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced dosing of the first patient in a multicenter Phase I/II clinical trial at the Dana-Farber/Harvard Cancer Center of duvelisib in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

6 Sep 2018

Researchers predict how splicing errors impact disease risk

No one knows how many times in a day, or even an hour, the trillions of cells in our body need to make proteins.

31 Aug 2018

Protein modifications that indicate disease

Researchers from the University of Zurich can, for the first time, precisely characterize the protein modification ADP-ribosylation for all proteins in a tissue sample.

28 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Adherence to ovarian cancer screening guidelines may be lower among physicians with nonprofessional cancer experience

A new study has found that physicians with nonprofessional experience of cancer were less likely to report adhering to recommendations against screening for ovarian cancer compared with physicians without this experience.

24 Aug 2018

Breastfeeding may reduce risk for stroke in post-menopausal women

Breastfeeding is not only good for babies, there is growing evidence it may also reduce the risk for stroke in post-menopausal women who reported breastfeeding at least one child, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

22 Aug 2018

UCLA professor shares five facts about ovarian cancer

Ovarian cancer can be beat. Dr. Sanaz Memarzadeh, a UCLA professor in obstetrics and gynecology and member of the UCLA Jonsson Comprehensive Cancer Center, is convinced of it.

22 Aug 2018

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

20 Aug 2018

Ovarian cancer screening influenced by unconscious bias, study shows

What do shark attack, the lottery and ovarian cancer screening having in common? It turns out our judgments about these things are all influenced by unconscious bias.

17 Aug 2018

New model of genetically engineered immune cells may help fight solid tumors

Scientists at Memorial Sloan Kettering Cancer Center announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.

15 Aug 2018

Scientists identify mutational signatures in ovarian cancer

Scientists have identified distinct patterns of genetic mutation among patients with ovarian cancer that could help them personalise treatment in the future.

14 Aug 2018

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

More than two-thirds of women with ovarian cancer have high-grade serous carcinoma. Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point it may not be possible to fully remove the tumor.

14 Aug 2018

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Johns Hopkins researchers in collaboration with Insilico Medicine, a biotechnology company based in Rockville Maryland, identify that silencing of the GULP1 gene expression by methylation plays an important role in ovarian carcinogenesis.

7 Aug 2018

Researchers discover new mechanism linked to inherited breast, ovarian cancer

Researchers from Manchester University NHS Foundation Trust and The University of Manchester have identified a new mechanism which switches off a gene in families affected by breast and ovarian cancer.

3 Aug 2018

BRAF inhibitors may be effective at treating rare ovarian cancer, study shows

New research has shown that ovarian cancer patients with a tumor mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.

30 Jul 2018

Researchers discover various mechanisms of resistance to cancer therapy

An international research team under the co-direction of the University of Bern and the Netherlands Cancer Institute has discovered various mechanisms of resistance to cancer therapy. The findings help researchers to understand the self-repair of cancer cells after a therapy and thus help to fight resistant tumours more efficiently.

30 Jul 2018

Study uncovers new protein complex that shields broken DNA ends

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

19 Jul 2018

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Researchers reveal how rapidly spreading ovarian cancer cells take the next steps

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Researchers predict how splicing errors impact disease risk

Protein modifications that indicate disease

Tips to know your ovarian cancer risk and symptoms

Adherence to ovarian cancer screening guidelines may be lower among physicians with nonprofessional cancer experience

Breastfeeding may reduce risk for stroke in post-menopausal women

UCLA professor shares five facts about ovarian cancer

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Ovarian cancer screening influenced by unconscious bias, study shows

New model of genetically engineered immune cells may help fight solid tumors

Scientists identify mutational signatures in ovarian cancer

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Researchers discover new mechanism linked to inherited breast, ovarian cancer

BRAF inhibitors may be effective at treating rare ovarian cancer, study shows

Researchers discover various mechanisms of resistance to cancer therapy

Study uncovers new protein complex that shields broken DNA ends

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in